Nearly three years ago, Netflix (NASDAQ: NFLX ) �CEO Reed Hastings angered many fans when he announced the company's DVD delivery business would be split from the video streaming segment into a service called Qwikster. Angry customers revolted, resulting in canceled memberships and a plummeting stock price. However, many astute investors jumped in and picked up a high-quality company at a discount.
What happened over the next three years was simply astounding. After Netflix briefly touched a low-water mark in the mid-$60s per share, it initiated a 600% upward climb to its current price, near $430. And while some of the initial drop was due to overly bearish investors, much was due to Netflix's operations themselves.�Moving forward, the next leg of growth will be provided by Netflix's international operations.�
International's short history
Netflix's international business has a rather short history. Starting by moving to Canada�in 2010,� the company quickly added a host of countries to its international�streaming roster: the U.K., Ireland, Norway, Denmark, and Mexico, among others. Today the company is in more than 40 countries, with more than 54 million paying members. Of those members, 24% are international streaming members.
Top 10 Semiconductor Stocks To Watch Right Now: Alere Inc (ALR)
Alere Inc., incorporated on May 11, 2001, is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company�� segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.
Professional Diagnostics
Professional diagnostics are generally designed to assist medical professionals in both preventative and interventional medicine, and include testing and monitoring performed in hospitals, laboratories and doctors' offices and, increasingly, patient self-testing, which the Company defines as testing or monitoring performed at home under the supervision of a medical professional. Professional diagnostic products provide for qualitative or quantitative analysis of patient samples for evidence of a specific medical condition, disease state or toxicological state or to measure response to therapy. The point-of-care market for rapid diagnostic products includes all areas where a patient is assessed or diagnosed, including hospitals, laboratories, physician offices, specialized mobile clinics, emergency rooms, rapid-response laboratories and patient health screening locations.
The Company's Alere Cholestech LDX System is a point-of-care monitor of blood cholesterol and related lipids which is used to test patients at risk of, or suffering from, heart disease and related conditions. The Alere Cholestech LDX System makes it possible to provide ! a complete lipid profile with tests for total cholesterol, high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL), triglycerides, and glucose. The Company's Alere INRatio System is an easy-to-use, hand-held blood coagulation monitoring system for use by patients and healthcare professionals in the management of warfarin, a commonly prescribed medication used to prevent blood clots. The Company also offers the epoc Blood Analysis System for bloods gas, electrolyte and metabolite testing, which is manufactured by its recently acquired Epocal division. The epoc (enterprise point-of-care) platform is a point-of-care analysis system which provides Wireless bedside blood gas, electrolyte and metabolite measurement testing solutions and complements the Company's Alere Triage products in cardiology and emergency room settings.
The Company develops and markets a range of point-of-care tests for influenza A/B, RSV, strep throat, pneumonia, C. difficile, infectious mononucleosis, HIV, herpes simplex virus (HSV-2), hepatitis C (HCV), hepatitis B (HBV), malaria, lyme disease, Chlamydia, H. pylori, rubella and other infectious diseases. The Company's tests for infectious disease are sold under brand names that include Alere, Alere Determine, Acceava, BinaxNOW, Clearview, DoubleCheckGold, Panbio, SD, TECHLAB and Alere TestPack. In addition to point-of-care products, the Company also offers a line of indirect fluorescent antibody, or IFA, assays for over 20 viral, bacterial and autoimmune diseases, a full line of serology diagnostic products covering a range of disease categories and over 50 enzyme-linked immunosorbent assay (ELISA), tests for a range of infectious and autoimmune diseases, as well as a full line of automated instrumentation for processing ELISA tests.
The Company offers laboratory-based testing services throughout Europe under the name Alere Toxicology, formerly Concateno, and in the United States under the names Alere Toxicology Services, or! Alere To! xicology, and Redwood Toxicology Laboratory, or Redwood. The Company offers point-of-care diabetes products, including its Afinion Analyzer System and its NycoCard System. The Company's Alere Connect products include HealthPAL and HealthCOM.
Health Information Solutions
The Company's health information solutions are designed to provide physicians with actionable data that allows them to make more decisions in real time, deliver quality care, and put the individuals they treat on a pathway to better health. The Company offers a range of software-based analytics, clinical decision support tools, and accountable cares programs that enable healthcare providers to initiate earlier interventions, personalize treatment plans, lower costs by reducing hospital readmissions, and measure improvements in outcomes at both a patient and population level. With this range of scalable solutions, the Company is able to support healthcare practitioners in the transition to accountable care, as well as in meeting the new pay-for-performance guidelines set by the Centers for Medicare & Medicaid Services (CMS).
The Company's Women's and Children's Health division delivers a range of obstetrical care services that range from risk assessments focused on identifying women who may experience pregnancy complications to a neonatal program that supports early infant care management. The Company offers home-based obstetrical monitoring for pregnant women with medical or pregnancy-related problems that could puts their health or the health of their babies at risk. The Company also delivers telephonic and home-based nursing services that support improved clinical outcomes. The Company offers a suite of integrated wellness programs and resources that is designed to reduce participant health risks and healthcare-related costs. The Company's wellness programs include screening for risk factors associated with chronic disease, particularly tobacco use, poor nutrition, physical inactivity, and chron! ic stress! .
The Company offers services designed to support anticoagulation management for patients who takes warfarin to control their risk for stroke and clotting disorders. Alere Home Monitoring, the Company's patient self-testing business, assists patients in acquiring home INR monitors and with insurance coverage determinations and provides physicians with a comprehensive model that allows them to incorporate patient self-testing into their practices.
Consumer Diagnostics
The Company's consumer diagnostic products consist of the Company's First Check brand of over-the-counter drug tests for at-home testing for up to seven illicit drugs and five prescription drugs, as well as First Check brand over-the-counter tests for cholesterol monitoring. The Company also sells Balance Activ Vaginal Gel directly to consumers and healthcare professionals for the treatment of bacterial vaginosis without antibiotics.
The Company competes with Abbott, Siemens, Beckman Coulter, Johnson & Johnson, Roche, Abaxis Medical Diagnostics, International Technidyne Corporation, INOVA Diagnostics, DiaSorin, Diamedx and Qiagen.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Alere (NYSE: ALR ) , whose recent revenue and earnings are plotted below.
Best International Stocks To Buy Right Now: Generale de Sante SA (GDS)
Generale de Sante SA, (also GDS), is a France-based provider of private hospital healthcare services. The Company offers a range of hospital services and, in partnership with independent medical specialists, delivers a spectrum of care services. Generale de Sante SA also provides services in the areas of mental health; oncology and radiation therapy; care for alcohol abuse and obesity; rehabilitation, such as cardiac rehabilitation and orthopedic and neurological reeducation, and diagnostics, such as medical imaging and analysis. It operates through one wholly owned subsidiary, CGS (Compagnie Generale de Sante). As of March 31, 2011, Sante Developpement Europe held a 54.47% stake in the Company�� shareholdings. Advisors' Opinion:- [By stanh30]
It does not matter if it�� a penny stock, all that matters is whether or not my reasoning is correct. However, in June the Global Depositary Shares (GDS) will undergo a 60:1 reverse split (pending shareholder approval) and the stock will no longer be a penny stock. Unfortunately the reverse split will occur after the June 12, 2014 record date for determining the persons and/or entities liable to the Depositary for the annual fee of $0.02 per Global Depositary shares for depositary services. This is an enormous fee for GDS shares, but one that I will pay due to the extreme undervaluation. Just remember that if you purchase the GDS shares on or before June 12th you are effectively paying an extra $0.02 per share.
Best International Stocks To Buy Right Now: Red Robin Gourmet Burgers Inc.(RRGB)
Red Robin Gourmet Burgers, Inc., together with its subsidiaries, develops, operates, and franchises casual-dining restaurants in the United States and Canada. As of February 16, 2012, the company operated 465 Red Robin restaurants, including 328 company-owned restaurants and 137 restaurants operating under franchise agreements. Its restaurants offer gourmet burgers, as well as various salads, soups, appetizers, entrees, desserts, and signature Mad Mixology alcoholic and non-alcoholic specialty beverages Red Robin Gourmet Burgers, Inc. was founded in 1969 and is headquartered in Greenwood Village, Colorado.
Advisors' Opinion:- [By Lisa Levin]
Red Robin Gourmet Burgers (NASDAQ: RRGB) shares climbed 3.04% to $54.23. The volume of Red Robin shares traded was 398% higher than normal. On Thursday, Red Robin reported downbeat second-quarter profit.
- [By Jake L'Ecuyer]
Red Robin Gourmet Burgers (NASDAQ: RRGB) was also up, gaining 10.99 percent to $73.87 after Bank of America upgraded the stock from Underperform to Buy.
Best International Stocks To Buy Right Now: Lennar Corp.(LEN)
The third largest U.S. homebuilder by revenue reported exceptional Q3 results, as its earnings more than quadrupled, primarily as a result of an increase in new-home demand. The reported net income of 40c was well ahead of last year's 11c, and the forecasted 28c.
According to the company's CEO, Stuart Miller, "The homebuilding business is beginning to revert to normal, and that's a positive for the U.S. economy in general, which is in turn good for sustained recovery in the housing market. Overall demand has been improving and we've seen a consistent sales pace at improving prices."
LEN's contract backlog, which is an indicator of future sales, rose by a whopping 79% on a YoY basis. Its average selling price of delivered homes also increased to $258,000 from last year's $247,000.
Advisors' Opinion:- [By Blake Bos]
In this video, Blake looks at lumber prices compared to housing starts to help give investors a frame of reference.� What will this mean for homebuilders like�Lennar (NYSE: LEN ) �and PulteGroup (NYSE: PHM ) ?
- [By Ben Levisohn]
Shares of Toll Brothers have gained 1.9% to $36.32 at 11:59 a.m., but its strength hasn’t really translated into big days for other home builders. KB Home (KBH) has gained 0.4% to $16.65, DR Horton (DHI) has risen 0.4% to $23.22 and Lennar (LEN) has dipped 0.3% to $40.37.
Best International Stocks To Buy Right Now: Guidewire Software Inc (GWRE)
Guidewire Software, Inc. (Guidewire), incorporated in 2001, is a provider of system software to the global property and casualty insurance industry. The Company�� solutions serve as the transactional systems-of-record for, and enable the functions of a property and casualty insurance carrier�� business, such as underwriting and policy administration, claims management and billing. Guidewire has developed a suite of configurable applications that are delivered through a Web-based interface and can be deployed either on-premise or in cloud environments. Its Guidewire InsuranceSuite includes Guidewire PolicyCenter, Guidewire ClaimCenter and Guidewire BillingCenter applications, which enable a range of property and casualty insurance operations. The Company derives its revenues from licensing software applications, providing maintenance support and providing professional services, principally consisting of implementation and training services. Guidewire�� license revenues are primarily generated through annual license fees. In May 2013, Guidewire Software Inc acquired Millbrook Inc.
Guidewire PolicyCenter
Guidewire PolicyCenter is the Company�� underwriting and policy administration application that serves as a system-of-record that supports the policy lifecycle, including product definition, underwriting, quoting, binding, issuances, endorsements, audits, cancellations and renewals. PolicyCenter integrates the underwriting process of evaluating risks and establishing the appropriate policy terms and pricing.
Guidewire ClaimCenter
Guidewire ClaimCenter is the Company�� claims management application for claim intake, assessment, settlement and processing of claim-related financial transactions. ClaimCenter provides property and casualty insurance carriers with the tools built within a business rules-based claims application.
Guidewire BillingCenter
Guidewire BillingCenter is its billing and receivables management a! pplication. It automates the billing lifecycle, enables the design of a range of billing and payment plans, manages agent commissions and integrates with external payment systems. BillingCenter handles direct and agency billing for all property and casualty insurance lines of business, and its dual-entry accounting core integrates with a property and casualty insurance carrier�� general ledger.
The Company competes with Accenture, Computer Sciences Corporation, MajescoMastek, Tata Consultancy Services Limited, AQS, Inc., OneShield, Inc., StoneRiver, Inc., Oracle Corporation, Pegasystems Inc. and SAP AG.
Advisors' Opinion:- [By Rebecca McClay]
In earnings news today, a few companies are reporting after the closing bell, including H & R Block Inc. (NYSE: HRB), which is up about 1%. Pike Electric Corp. (NYES: PIKE), Guidewire Software Inc. (NYSE: GWRE), and Sigma Designs Inc. (Nasdaq: SIGM) are also reporting quarterly earnings late this afternoon.
Best International Stocks To Buy Right Now: Nu Skin Enterprises Inc.(NUS)
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements worldwide. The company sells its personal care products under the Nu Skin brand; and nutritional supplements under the Pharmanex brand. Its personal care product line includes core systems, targeted treatments, total care, cosmetic, and Epoch, a product formulated with botanical ingredients. The company?s nutritional supplements product line comprises micronutrient supplements, targeted solution supplements, and weight management products. It also sells Vitameal, which are nutritious meal products for starving children or purchased for personal food storage. In addition, the company offers other products and services consisting of digital content storage, water purifiers, and other household products. It sells its products primarily through a network of independent distributors in north Asia, the Americas, Greater China, Europe, and the south Asia/Pacific. The c ompany also operates retail stores to sell its products in China. As of December 31, 2010, Nu Skin Enterprises operated 40 stores throughout China. The company was founded in 1984 and is headquartered in Provo, Utah.
Advisors' Opinion:- [By Shauna O'Brien]
Nu Skin Enterprises, Inc. (NUS) reported higher fourth quarter earnings on Monday, which came in above analysts’ estimates.
NUS Earnings in Brief
NUS reported earnings of $2.02 per share, up from 97 cents per share a year ago.� Revenue increased 82% to�$1.056 billion. On average, analysts expected to see earnings of $1.99 per share and $1.07 billion in revenue. Revenue for FY2013 rose 49% to�$3.177 billion. EPS for the year was $5.94 per share.CEO Commentary
Truman Hunt, president and CEO of NUS commented:�”We are pleased to report solid growth for the fourth quarter and full year of 2013.�We achieved this growth by continuing to increase our consumer base and sales force, while also executing the limited-time offering of our ageLOC TR90 weight management and body shaping system.”
NUS Raises Dividend
NUS announced that it has increased its dividend by 15% to 34.5 cents. The dividend will be paid on March 26 to shareholders of record on March 14.
Stock Performance�
Nu Skin Enterprises shares were down $4.55, or 5.45%, during pre-market trading Monday. The stock is down 40% YTD.
- [By Ben Levisohn]
Shares of Herbalife have dropped 11% to $54.08 at 3:30 p.m. while Nu Skin (NUS) has fallen 2.4% to $60.91 and Usana Health Services (USNA) has declined 7% to $67.75.
- [By Garrett Cook]
Nu Skin Enterprises (NYSE: NUS) shares tumbled 22.75 percent to $44.74 after the company reported downbeat quarterly results and issued a weak forecast.
- [By Ben Levisohn]
Barron’s Bill Alpert made his own case against Herbalife on May 12, 2012, and included Nu Skin (NUS), which uses a similar business model. It’s a must read for anyone who wants a skeptical view of Herbalife without the fireworks that come when prominent hedge-fund managers go head to head.
No comments:
Post a Comment